Health Care & Hospital Law,
Civil Litigation
Nov. 3, 2021
Plaintiffs to seek review of lost $52B suit against opioid makers
Reacting to the ruling, the pharmaceutical companies said their marketing of opioids such as Oxycontin, Kadian, and Duragesic, were entirely legal and appropriate, as the judge had said in his ruling.




After an Orange County judge tentatively ruled four major drug companies were not liable for the state's opioid crisis, a plaintiffs committee seeking $52 billion on behalf of the state, vowed to appeal the decision.
"The people of California will have their opportunity to pursue justice on appeal and ensure no opioid manufacturer can engage in reckless corporate practices that compromise public health in the state for their own profit," T...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In